Published in Child Adolesc Psychiatry Ment Health on February 27, 2008
A systematic review of the long-term outcome of early onset schizophrenia. BMC Psychiatry (2012) 1.25
College Students: Mental Health Problems and Treatment Considerations. Acad Psychiatry (2014) 0.80
Safety, tolerability, and efficacy of quetiapine in youth with schizophrenia or bipolar I disorder: a 26-week, open-label, continuation study. J Child Adolesc Psychopharmacol (2013) 0.78
Long term functioning in early onset psychosis: two years prospective follow-up study. Behav Brain Funct (2011) 0.78
Predictors of outcome in early-onset psychosis: a systematic review. NPJ Schizophr (2015) 0.78
The abilities of improved schizophrenia patients to work and live independently in the community: a 10-year long-term outcome study from Mumbai, India. Ann Gen Psychiatry (2009) 0.75
CPA Guidelines for the Pharmacological Treatment of Schizophrenia Spectrum and Other Psychotic Disorders in Children and Youth. Can J Psychiatry (2017) 0.75
Long-term effectiveness of electroconvulsive therapy in adolescents with schizophrenia spectrum disorders. Eur Child Adolesc Psychiatry (2014) 0.75
One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry (1994) 5.29
Developmental precursors of child- and adolescent-onset schizophrenia and affective psychoses: diagnostic specificity and continuity with symptom dimensions. Br J Psychiatry (2003) 1.32
Childhood-onset schizophrenia: the severity of premorbid course. J Am Acad Child Adolesc Psychiatry (1995) 1.21
Child and adolescent (juvenile onset) schizophrenia. A case control study of premorbid developmental impairments. Br J Psychiatry (1995) 1.19
Childhood and adolescent schizophrenic, bipolar, and schizoaffective disorders: a clinical and outcome study. J Am Acad Child Adolesc Psychiatry (1991) 1.14
How does gender influence age at first hospitalization for schizophrenia? A transnational case register study. Psychol Med (1989) 1.06
The psychosocial outcome of adolescent-onset schizophrenia: a 12-year followup. Schizophr Bull (2000) 1.05
Childhood-onset schizophrenia: a followup study. Schizophr Bull (1994) 1.04
The course of schizophrenia in the light of modern follow-up studies: the ABC and WHO studies. Eur Arch Psychiatry Clin Neurosci (1999) 1.02
The long-term course of childhood-onset schizophrenia: a 42-year followup. Schizophr Bull (1997) 1.01
Long-term course of adolescent schizophrenia. Schizophr Bull (2005) 0.97
Forty-two-years later: the outcome of childhood-onset schizophrenia. J Neural Transm (Vienna) (2006) 0.96
Psychotic disorders diagnosed in adolescence. Outcome at age 30 years. J Child Psychol Psychiatry (1993) 0.94
[Schizophrenia. Clinical course and social psychiatric long term examinations of schizophrenic patients hospitalized in Bonn from 1945-1959]. Monogr Gesamtgeb Psychiatr Psychiatry Ser (1979) 0.93
Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. I: nosology, sex and age of onset. Br J Psychiatry (1996) 0.92
Early-onset schizophrenia: a 15-year follow-up. Eur Child Adolesc Psychiatry (2005) 0.91
[Lifestyle and age of schizophrenics. A catamnestic long-term study into old age]. Monogr Gesamtgeb Psychiatr Psychiatry Ser (1976) 0.90
Course of patients diagnosed as having schizophrenia during first episode occurring under age 18 years. Eur Arch Psychiatry Clin Neurosci (1995) 0.88
Approaches to knowledge and understanding of schizophrenia. Schizophr Bull (1987) 0.79
[Eppendorf Schizophrenia Inventory (ESI) vs. Frankfurt Complaint Questionnaire (FCQ). Direct comparison in a clinical trial]. Nervenarzt (2005) 0.79
Course of adolescent psychotic disorder with schizoaffective episodes. Eur Child Adolesc Psychiatry (1997) 0.79
Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2010) 3.13
Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. Am J Psychiatry (2012) 2.48
Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm (Vienna) (2008) 2.43
Obsessive-compulsive disorder in children and adolescents. Dtsch Arztebl Int (2011) 2.10
Strong genetic evidence of DCDC2 as a susceptibility gene for dyslexia. Am J Hum Genet (2005) 1.94
Case-control genome-wide association study of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2010) 1.86
Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet (2011) 1.63
Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2008) 1.48
A locus on 2p12 containing the co-regulated MRPL19 and C2ORF3 genes is associated to dyslexia. Hum Mol Genet (2007) 1.32
Empathy in children with autism and conduct disorder: group-specific profiles and developmental aspects. J Child Psychol Psychiatry (2011) 1.23
Developmental comorbidity in attention-deficit/hyperactivity disorder. Atten Defic Hyperact Disord (2010) 1.13
Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: genome-wide association study of both common and rare variants. Am J Med Genet B Neuropsychiatr Genet (2013) 1.11
High loading of polygenic risk for ADHD in children with comorbid aggression. Am J Psychiatry (2013) 1.10
Genome-wide association study in German patients with attention deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2011) 1.09
Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in children and adolescents with obsessive-compulsive disorder. Int J Neuropsychopharmacol (2005) 1.08
Cross-disorder analysis of bipolar risk genes: further evidence of DGKH as a risk gene for bipolar disorder, but also unipolar depression and adult ADHD. Neuropsychopharmacology (2011) 1.07
Further evidence for DYX1C1 as a susceptibility factor for dyslexia. Psychiatr Genet (2009) 1.06
Long-term outcome and prognosis of dissociative disorder with onset in childhood or adolescence. Child Adolesc Psychiatry Ment Health (2008) 1.04
Altered response control and anterior cingulate function in attention-deficit/hyperactivity disorder boys. Clin Neurophysiol (2004) 1.04
Investigation of the DCDC2 intron 2 deletion/compound short tandem repeat polymorphism in a large German dyslexia sample. Psychiatr Genet (2008) 1.00
Investigation of interaction between DCDC2 and KIAA0319 in a large German dyslexia sample. J Neural Transm (Vienna) (2008) 1.00
The extent of social anxiety in combination with mental disorders. Eur Child Adolesc Psychiatry (2006) 0.99
Genetics of early-onset obsessive-compulsive disorder. Eur Child Adolesc Psychiatry (2010) 0.97
A prospective 12-week study of quetiapine in adolescents with schizophrenia spectrum disorders. J Child Adolesc Psychopharmacol (2007) 0.97
Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample. J Epidemiol Community Health (2009) 0.96
Novel mutations of the extraneuronal monoamine transporter gene in children and adolescents with obsessive-compulsive disorder. Int J Neuropsychopharmacol (2007) 0.96
Elevated physical activity and low leptin levels co-occur in patients with anorexia nervosa. J Clin Endocrinol Metab (2003) 0.95
A systematic review on olfaction in child and adolescent psychiatric disorders. J Neural Transm (Vienna) (2012) 0.94
Mapping for dyslexia and related cognitive trait loci provides strong evidence for further risk genes on chromosome 6p21. Am J Med Genet B Neuropsychiatr Genet (2010) 0.90
Case-control study of six genes asymmetrically expressed in the two cerebral hemispheres: association of BAIAP2 with attention-deficit/hyperactivity disorder. Biol Psychiatry (2009) 0.90
Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder? Environ Health Perspect (2007) 0.89
Clinical drug monitoring in child and adolescent psychiatry: side effects of atypical neuroleptics. J Child Adolesc Psychopharmacol (2006) 0.89
Improved odor sensitivity in attention-deficit/hyperactivity disorder. Biol Psychiatry (2008) 0.88
Common obesity risk alleles in childhood attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2013) 0.88
Weight gain in children and adolescents during 45 weeks treatment with clozapine, olanzapine and risperidone. J Neural Transm (Vienna) (2008) 0.88
Evidence for the late MMN as a neurophysiological endophenotype for dyslexia. PLoS One (2012) 0.87
Developmental dyslexia--recurrence risk estimates from a german bi-center study using the single proband sib pair design. Hum Hered (2005) 0.87
A double-blind, randomized, placebo/active controlled crossover evaluation of the efficacy and safety of Ritalin ® LA in children with attention-deficit/hyperactivity disorder in a laboratory classroom setting. J Child Adolesc Psychopharmacol (2010) 0.87
Influence of a genetic variant of the neuronal growth associated protein Stathmin 1 on cognitive and affective control processes: an event-related potential study. Am J Med Genet B Neuropsychiatr Genet (2011) 0.86
Multicenter P300 brain mapping of impaired attention to cues in hyperkinetic children. J Am Acad Child Adolesc Psychiatry (2002) 0.86
SNP variations in the 7q33 region containing DGKI are associated with dyslexia in the Finnish and German populations. Behav Genet (2011) 0.86
Expression analyses of the mitochondrial complex I 75-kDa subunit in early onset schizophrenia and autism spectrum disorder: increased levels as a potential biomarker for early onset schizophrenia. Eur Child Adolesc Psychiatry (2009) 0.86
Cognitive behavioral therapy of socially phobic children focusing on cognition: a randomised wait-list control study. Child Adolesc Psychiatry Ment Health (2011) 0.85
Abnormal affective responsiveness in attention-deficit/hyperactivity disorder: subtype differences. Biol Psychiatry (2008) 0.85
Proteomic research in psychiatry. J Psychopharmacol (2010) 0.84
Increased mRNA levels of the mitochondrial complex I 75-kDa subunit. A potential peripheral marker of early onset schizophrenia? Eur Child Adolesc Psychiatry (2006) 0.84
Evaluation of the efficacy and effectiveness of a structured disorder tailored psychotherapy in ADHD in adults: study protocol of a randomized controlled multicentre trial. Atten Defic Hyperact Disord (2010) 0.83
Prefrontal oxygenation during working memory in ADHD. J Psychiatr Res (2009) 0.83
Pharmacotherapy in depressed children and adolescents. World J Biol Psychiatry (2011) 0.82
Serum protein profiling and proteomics in autistic spectrum disorder using magnetic bead-assisted mass spectrometry. Eur Arch Psychiatry Clin Neurosci (2009) 0.82
Pilot study on HTR2A promoter polymorphism, -1438G/A (rs6311) and a nearby copy number variation showed association with onset and severity in early onset obsessive-compulsive disorder. J Neural Transm (Vienna) (2011) 0.82
Candidate system analysis in ADHD: evaluation of nine genes involved in dopaminergic neurotransmission identifies association with DRD1. World J Biol Psychiatry (2012) 0.81
[Genetics of dyslexia]. Z Kinder Jugendpsychiatr Psychother (2006) 0.81
Familiality and molecular genetics of attention networks in ADHD. Am J Med Genet B Neuropsychiatr Genet (2010) 0.81
[Therapeutic drug monitoring in child and adolescent psychiatry--practical recommendations]. Z Kinder Jugendpsychiatr Psychother (2006) 0.81
Exploring DRD4 and its interaction with SLC6A3 as possible risk factors for adult ADHD: a meta-analysis in four European populations. Am J Med Genet B Neuropsychiatr Genet (2011) 0.81
Common variants in the TPH1 and TPH2 regions are not associated with persistent ADHD in a combined sample of 1,636 adult cases and 1,923 controls from four European populations. Am J Med Genet B Neuropsychiatr Genet (2010) 0.81
Altered frontal and temporal brain function during olfactory stimulation in adult attention-deficit/hyperactivity disorder. Neuropsychobiology (2010) 0.81
DIRAS2 is associated with adult ADHD, related traits, and co-morbid disorders. Neuropsychopharmacology (2011) 0.80
[Phenomenology and co-morbidity of childhood onset obsessive compulsive disorder]. Z Kinder Jugendpsychiatr Psychother (2007) 0.80
[Children and adolescents with obsessive-compulsive disorders]. Z Kinder Jugendpsychiatr Psychother (2009) 0.80
[Memorandum for improving research performance and for supporting the future medical generation in child and adolescent psychiatry, psychosomatic medicine and psychotherapy]. Z Kinder Jugendpsychiatr Psychother (2006) 0.80
DCLK1 variants are associated across schizophrenia and attention deficit/hyperactivity disorder. PLoS One (2012) 0.79
Bone mineral density in partially recovered early onset anorexic patients - a follow-up investigation. Child Adolesc Psychiatry Ment Health (2010) 0.79
No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy. Toxicol Lett (2008) 0.79
Pervasive refusal syndrome. Three German cases provide further illustration. Z Kinder Jugendpsychiatr Psychother (2011) 0.79
Olfaction in child and adolescent anorexia nervosa. J Neural Transm (Vienna) (2011) 0.78
Effects of methylphenidate on olfaction and frontal and temporal brain oxygenation in children with ADHD. J Psychiatr Res (2011) 0.78
Effectiveness and tolerability of olanzapine in the treatment of adolescents with schizophrenia and related psychotic disorders: results from a large, prospective, open-label study. J Child Adolesc Psychopharmacol (2008) 0.78
A randomized, rater-blinded, crossover study comparing the clinical efficacy of Ritalin(®) LA (methylphenidate) treatment in children with attention-deficit hyperactivity disorder under different breakfast conditions over 2 weeks. Atten Defic Hyperact Disord (2010) 0.77
[Quantitative effect of treatment with methylphenidate on EEG--a pilot study]. Z Kinder Jugendpsychiatr Psychother (2007) 0.77
The relation between dosage, serum concentrations, and clinical outcome in children and adolescents treated with sertraline: a naturalistic study. Ther Drug Monit (2013) 0.77
Further evidence for a susceptibility locus contributing to reading disability on chromosome 15q15-q21. Psychiatr Genet (2008) 0.77
Early attentional deficits in an attention-to-prepulse paradigm in ADHD adults. J Abnorm Psychol (2010) 0.77
The Kiddie-SADS allows a dimensional assessment of externalizing symptoms in ADHD children and adolescents. Atten Defic Hyperact Disord (2009) 0.77
Olanzapine overdose in children and adolescents: two case reports and a review of the literature. J Child Adolesc Psychopharmacol (2005) 0.77
Brain-derived neurotrophic factor V66M polymorphism in childhood-onset obsessive-compulsive disorder. Int J Neuropsychopharmacol (2005) 0.76
[Paroxetine versus clomipramine in female adolescents suffering from anorexia nervosa and depressive episode--a retrospective study on tolerability, reasons for discontinuing the antidepressive treatment and different outcome measurements]. Z Kinder Jugendpsychiatr Psychother (2004) 0.76
[Treatment of social phobia in childhood and adolescence]. Z Kinder Jugendpsychiatr Psychother (2006) 0.76
Autonomic hypoactivity in boys with attention-deficit/hyperactivity disorder and the influence of methylphenidate. World J Biol Psychiatry (2013) 0.76
Does the treatment of maternal attention deficit and hyperactivity disorder (ADHD) enhance the efficacy of a behavioural parent training for the treatment of their children's ADHD? Study protocol of a randomized controlled multicentre trail. Atten Defic Hyperact Disord (2009) 0.76
Transmission disequilibrium analysis of the functional 5-HT3A receptor variant C178T in early-onset obsessive compulsive-disorder. J Psychopharmacol (2007) 0.76
Structural abnormality of the substantia nigra in children with attention-deficit hyperactivity disorder. J Psychiatry Neurosci (2010) 0.76
Olfactory deficits in deletion syndrome 22q11.2. Schizophr Res (2011) 0.76
Prospective follow-up studies found no chromosomal mutagenicity of methylphenidate therapy in ADHD affected children. Toxicol Lett (2009) 0.76
Olanzapine in male and female adolescent patients with schizophrenia and related disorders: minor sex differences in outcomes. J Clin Psychopharmacol (2010) 0.75
Correspondence (reply): In Reply. Dtsch Arztebl Int (2008) 0.75
An association study of sequence variants in the forkhead box P2 (FOXP2) gene and adulthood attention-deficit/hyperactivity disorder in two European samples. Psychiatr Genet (2012) 0.75
[What are the aims of the German Journal for Child and Adolescent Psychiatry and Psychotherapy?]. Z Kinder Jugendpsychiatr Psychother (2010) 0.75
Haplotype co-segregation with attention deficit-hyperactivity disorder in unrelated German multi-generation families. Am J Med Genet B Neuropsychiatr Genet (2013) 0.75
[Family in retreat]. Z Kinder Jugendpsychiatr Psychother (2010) 0.75
[Cognitive and emotional empathy in children with ADHD and conduct disorder]. Z Kinder Jugendpsychiatr Psychother (2011) 0.75
[Psychometric properties and clinical norms for the German version (SPAIK) of the Social Phobia and Anxiety Inventory for Children (SPAI-C)]. Z Kinder Jugendpsychiatr Psychother (2011) 0.75